Narrow search
Showing 1 - 10 of 45
Cover Image
Have newer cardiovascular drugs reduced hospitalization? : Evidence from longitudinal country-level data on 20 OECD countries, 1995 - 2003
Lichtenberg, Frank R. - 2008
"This study examines the effect of changes in the vintage distribution of cardiovascular system drugs on hospitalization and mortality due to cardiovascular disease using longitudinal country-level data. The vintage of a drug is the first year in which it was marketed anywhere in the world. We...
Persistent link: https://www.econbiz.de/10003716085
Cover Image
Importation and innovation
Lichtenberg, Frank R. - In: Economics of innovation and new technology 16 (2007) 5/6, pp. 403-417
Persistent link: https://www.econbiz.de/10003610272
Cover Image
Importation and innovation
Lichtenberg, Frank R. - 2006
Persistent link: https://www.econbiz.de/10003381044
Cover Image
Has medical innovation reduced cancer mortality?
Lichtenberg, Frank R. - 2010
Persistent link: https://www.econbiz.de/10003960210
Cover Image
Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000 - 2009
Lichtenberg, Frank R. - 2012
Persistent link: https://www.econbiz.de/10009574739
Cover Image
The effect of pharmaceutical innovation on longevity : patient level evidence from the 1996 - 2002 medical expenditure panel survey and linked mortality public-use files
Lichtenberg, Frank R. - In: Forum for health economics & policy : an evolving … 16 (2013) 1, pp. 1-33
Persistent link: https://www.econbiz.de/10009714421
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in France : 2000 - 2009
Lichtenberg, Frank R. - In: Economics and human biology 13 (2014), pp. 107-127
Persistent link: https://www.econbiz.de/10010386634
Cover Image
Has medical innovation reduced cancer mortality?
Lichtenberg, Frank R. - In: CESifo economic studies : CESifo, a joint initiative of … 60 (2014) 1, pp. 135-177
I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the period 2000–2009, by estimating difference-in-differences models using longitudinal (annual) data on ∼60 cancer sites (breast, colon, etc.). The outcome measure used is not...
Persistent link: https://www.econbiz.de/10010466909